This study identified that ATG4D was a target gene for miR-101-3p in NSCLC cells and inhibition of ATG4D reversed the role of miR-101-3p inhibitor on the sensitivity to cisplatin in NSCLC cells. This evidence concerns the gene ATG4D and non-small cell lung carcinoma.